Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.

Saved in:
Bibliographic Details
Title: Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.
Authors: Rajdev L; Icahn School of Medicine at Mount Sinai, New York, NY., King GG; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA., Lieu CH; University of Colorado Cancer Center, Denver, CO., Cohen SA; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA., Pant S; MD Anderson Cancer Center, Houston, TX., Uboha NV; University of Wisconsin, Madison, WI., Deming D; University of Wisconsin, Madison, WI., Malla M; University of Alabama, Birmingham, AL., Kasi A; University of Kansas Medical Center, Kansas City, KS., Klute K; University of Nebraska Medical Center, Omaha, NE., Spencer KR; New York University Grossman School of Medicine, New York, NY., Dasari A; MD Anderson Cancer Center, Houston, TX., Morris VK; MD Anderson Cancer Center, Houston, TX., Botta G; University of California San Diego, San Diego, CA., Lowy AM; University of California San Diego, San Diego, CA., O'Hara MH; University of Pennsylvania, Philadelphia, PA., Eads J; University of Pennsylvania, Philadelphia, PA., King D; Feinstein Institutes for Medical Research Northwell Health, Manhasset, NY., Shah MA; Weil-Cornell Medical College New York Presbyterian, New York, NY., Hong TS; Massachusetts General Hospital, Harvard Medical School, Boston, MA., Parikh A; Massachusetts General Hospital, Harvard Medical School, Boston, MA., Klempner SJ; Massachusetts General Hospital, Harvard Medical School, Boston, MA., Jabbour SK; Rutgers University, New Brunswick, NJ., Chawla A; Feinberg School of Medicine, Northwestern University, Chicago, IL., Molena D; Memorial Sloan Kettering Cancer Center, New York, NY., George TJ; University of Florida Health Cancer Center, Gainesville, FL., Gibson MK; Division Hematology & Oncology, Vanderbilt-Ingram Cancer Center, Nashville, TN., Allegra C; National Cancer Institute, Bethesda, MD., Goodman K; Icahn School of Medicine at Mount Sinai, New York, NY., Eng C; Division Hematology & Oncology, Vanderbilt-Ingram Cancer Center, Nashville, TN., Philip PA; Wayne State University, Henry Ford Health, Detroit, MI.
Source: JCO precision oncology [JCO Precis Oncol] 2025 Mar; Vol. 9, pp. e2400489. Date of Electronic Publication: 2025 Mar 06.
Publication Type: Journal Article; Consensus Statement
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-4284
DOI:10.1200/PO-24-00489